Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Receptor for RNL3/relaxin-3. Additionally we are shipping Relaxin 3 Receptor 1 Proteins (4) and Relaxin 3 Receptor 1 Kits (3) and many more products for this protein.
Showing 10 out of 66 products:
Human Polyclonal Relaxin 3 Receptor 1 Primary Antibody for WB - ABIN611195
Greene, Bahn, Masson, Rabbitts: The T-cell oncogenic protein HOX11 activates Aldh1 expression in NIH 3T3 cells but represses its expression in mouse spleen development. in Molecular and cellular biology 1998
Show all 3 references for ABIN611195
Human Monoclonal Relaxin 3 Receptor 1 Primary Antibody for IHC, ELISA - ABIN368640
Matsumoto, Kamohara, Sugimoto, Hidaka, Takasaki, Saito, Okada, Yamaguchi, Furuichi: The novel G-protein coupled receptor SALPR shares sequence similarity with somatostatin and angiotensin receptors. in Gene 2000
Show all 3 references for ABIN368640
we investigated the effect of Rxfp3 gene deletion in C57BL/6J mice on sucrose and alcohol self-administration and cue-induced reinstatement (RNST) of sucrose- and alcohol-seeking.
Rxfp3 KO mice displayed a stress-induced reduction in alcohol preference that was not observed in WT littermates.
This study demonstrated that Relaxin-3 (show RLN3 Antibodies) receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3 (show RLN3 Antibodies)/RXFP3 signalling in sustained arousal.
These findings are consistent with an earlier report of increased activity scores in rats acutely injected centrally with R3/I5, and further suggest a role for relaxin-3 (show RLN3 Antibodies)/RXFP3 signalling in promoting behavioural arousal.
Central injection of the RXFP3 agonists R3/I5 or H3 relaxin (0.5 nmol, icv) did not alter chow consumption in satiated mice relative to vehicle controls, during the 60 min after treatment.
Data provide evidence for the conserved nature of RLN3 (show RLN3 Antibodies)/RXFP3 systems in mammalian brain and the ability of RLN3 (show RLN3 Antibodies)/RXFP3 signaling to modulate "behavioral state" and an array of circuits involved in arousal, stress, affect, and cognition.
A distinct pattern of expression in brain, spinal cord, and dorsal root ganglia during development and in the mature brain hint at important functions of SALPR for differentiation and maintenance of the nervous system.(SALPR PROTEIN, MOUSE)
we demonstrated distinct patterns of signalling for H3 and H2 relaxin and R3(BDelta23-27)R/I5 at the RXFP3 receptor
Glu141 and Asp145 of the RXFP3 interact with the highly conserved arginine residues of relaxin-3 (show RLN3 Antibodies).
demonstrate the existence of an allosteric site for modulation of RXFP3
H3 relaxin potently activates all signaling pathways coupled to RXFP3, whereas H2 relaxin is an AP-1-biased ligand relative to H3 relaxin.
Methylation status of CIDEA (show CIDEA Antibodies), HAAO (show HAAO Antibodies) and RXFP3 had significant association with microsatellite instability in endometrial tumors.
GPCR135 (SALPR) is the receptor for relaxin-3 (show RLN3 Antibodies)
Substitution of the relaxin-3 (show RLN3 Antibodies) A-chain with the A-chain from insulin-like peptide 5 (show INSL5 Antibodies) results in a chimeric peptide that selectively activates GPCR135 and GPCR142 (show RXFP4 Antibodies).
functional response to H3 relaxin and other relaxin/insulin (show INS Antibodies) peptides of GPCR135 expressed in CHO (show COL11A1 Antibodies)-K1 cells was measured in the cytosensor microphysiometer and analyzed using inhibitors of signal transduction proteins
analysis of truncated human relaxin-2 (show RLN1 Antibodies) and -3 (H2 and H3) relaxin peptides and their binding and cAMP activities on RXFP1 (show RXFP1 Antibodies), RXFP2 (show RXFP2 Antibodies), and RXFP3
the N-terminus and EL2 (show SPTA1 Antibodies) domains of RXFP3 and RXFP4 (show RXFP4 Antibodies) are involved in ligand binding while TM2 (show TPM2 Antibodies), 3, and 5 are critical for receptor activation.
Receptor for RNL3/relaxin-3. Binding of the ligand inhibit cAMP accumulation (By similarity).
relaxin/insulin-like family peptide receptor 3
, relaxin 3 receptor 1
, G-protein coupled receptor SALPR
, RLN3 receptor 1
, g protein-coupled receptor SALPR homolog
, relaxin-3 receptor 1
, relaxin-3/INSL7 receptor 1
, somatostatin and angiotensin-like peptide receptor
, G-protein coupled receptor GPCR135
, g protein-coupled receptor SALPR
, relaxin family peptide receptor 3
, somatostatin- and angiotensin-like peptide receptor